Hitachi to Provide CNAO with Proton Therapy System

Tokyo, December 6, 2019 --- Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced that it has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.

In comprehensive public tender process, Hitachi has been selected to provide proton therapy system with latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.